Myanmar vs Syria: Cause of death, by non-communicable diseases, ages 15-59, male
Myanmar
53.5%
in 2021
Syria
54.7%
in 2021
Myanmar rank
83rd
Syria rank
80th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Myanmar
- Syria
How they compare
Syria currently reports 54.7% against 53.5% in Myanmar, a difference of 1.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Syria ahead.
Myanmar ranks 83rd and Syria ranks 80th of 185 countries.
Across the 3 decades both report, Myanmar averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Myanmar | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.0% | 76.0% | 26.9% | Syria |
| 2010s | 58.1% | 36.8% | 21.3% | Myanmar |
| 2020s | 58.5% | 50.2% | 8.3% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Myanmar or Syria?
- Syria, at 54.7% against 53.5% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Myanmar and Syria?
- 1.2%, with Syria ahead.
- How many years of comparable data are there for Myanmar and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Syria rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Myanmar ranks 83rd and Syria ranks 80th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.